Life Science Today
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs.
Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
The Niche Episode 028 – CAR T ON/OFF, Fujifilm, Affinivax, IconOVir, Lexeo Therapeutics
Turning CAR T on and off, Fujifilm’s $2 billion investment, Affinivax raises $226 million, and startups to watch
Sponsors
https://www.thescopemethod.com
Story References
10.1126/scitranslmed.abb6295
https://affinivax.com/affinivax-announces-226-million-series-c-financing-to-advance-its-pipeline-of-novel-maps-vaccines-targeting-infectious-diseases/
https://www.fujifilm.com/us/en/news/Fujifilm_to_Invest_2B_for_Cell_Culture_Manufacturing_Site
https://www.businesswire.com/news/home/20210105005224/en/IconOVir-Bio-Raises-77-Million-in-Series-A-Financing-to-Develop-Next-Generation-Oncolytic-Viruses-to-Treat-Solid-Tumors
https://www.lexeotx.com/
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
The Niche Podcast brings you interviews with industry experts top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.
The Niche Episode 027 – WHO, AstraZeneca, Phitonex, Axsome
AstraZeneca and W.H.O., vaccine I-told-you-so’s, Phitonex acquired by ThermoFisher, and Axsome reports success in migraine relief.
Sponsors
https://www.thescopemethod.com
Story References
https://www.rttnews.com/3157074/astrazeneca-s-covid-19-vaccine-cleared-by-expert-panel-in-india.aspx?refresh=1
https://www.who.int/news/item/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access
https://www.bbc.com/news/health-55280671
https://thermofisher.mediaroom.com/2020-12-31-Thermo-Fisher-Scientific-Acquires-Programmable-Dye-Platform-Pioneer-Phitonex
https://axsometherapeuticsinc.gcs-web.com/news-releases/news-release-details/axsome-therapeutics-announces-positive-efficacy-and-safety-0?field_nir_news_date_value[min]=
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
The Niche Podcast brings you interviews with industry experts top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.
The Niche Episode 026 – Top Trends from 2020
Trends in science from investors and immune-oncology to decentralized trials and basic research, we look back on 2020
Sponsors
https://www.thescopemethod.com
Story References
www.thenichepod.com
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
The Niche Podcast brings you interviews with industry experts top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.
The Niche Episode 025 – COVID, ERT & Bioclinica, Philips & BioTelemetry, AR Surgery
COVID updates, ERT & Bioclinica merge, Philips acquires BioTelemetry, and augmented reality surgeries.
Sponsors
https://www.thescopemethod.com
Story References
https://www.ellumehealth.com/2020/12/15/fda-authorizes-ellume-covid-19-home-test-as-first-over-the-counter-fully-at-home-diagnostic-test/
Wang et al., 2019 – https://pubs.acs.org/doi/10.1021/acsomega.9b00657
https://www.ert.com/featured-news/ert-and-bioclinica-to-merge-creating-a-global-leader-in-clinical-trial-endpoint-technology/
https://www.philips.com/a-w/about/news/archive/standard/news/press/2020/20201218-philips-to-become-a-global-leader-in-patient-care-management-solutions-for-the-hospital-and-the-home-through-the-acquisition-of-biotelemetry-inc.html
https://www.prnewswire.com/news-releases/seeing-is-believing-hospital-for-special-surgery-first-in-us-to-use-augmented-reality-platform-for-knee-replacement-301195275.html
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
The Niche Podcast brings you interviews with industry experts top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.
The Niche Episode 024 – Vaccine EAU, 70+ IPOs, Gilead
Vaccines are here, capitalizing on capital with IPOs, and Gilead targets Hepatitis D.
Sponsors
https://www.thescopemethod.com
Story References
https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19
https://www.abcellera.com/news/2020-12-10-abcellera-announces-pricing-of-ipo
https://www.certara.com/pressrelease/certara-announces-pricing-of-its-upsized-initial-public-offering/
https://ir.4dmoleculartherapeutics.com/news-releases/news-release-details/4d-molecular-therapeutics-announces-upsized-pricing-initial
https://www.nanobiotix.com/wp-content/uploads/2020/12/PR-Pricing.pdf
https://www.gilead.com/news-and-press/press-room/press-releases/2020/12/gilead-sciences-to-acquire-myr-gmbh
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
The Niche Podcast brings you interviews with industry experts top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.
The Niche Episode 023 – Everlywell, Bayer + Atara, and Moderna
Everlywell expands at-home testing, Bayer and Atara strike deal, and Moderna heads to the FDA.
Sponsors
https://www.thescopemethod.com
Story References
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
The Niche Podcast brings you interviews with industry experts top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.
Responses